Curiox was founded in 2008 to commercialize DropArray™ technology, which was initially developed by Namyong Kim, PhD and his group at the Institute of Bioengineering and Nanotechnology (IBN), a part of A*STAR. The venture was backed by Nanostart AG and Exploit Technologies, the commercialization arm of A*STAR.
In 2010, we received a large corporate investment from the Zicom Group, a Singaporean/ Australian conglomerate listed on the Australian Stock Exchange, that greatly accelerated our product development timeline and enabled expansion into global markets.
More recently, we introduced our Laminar Wash™ technology, which automates cell processing and enables highly reproducible and high-throughput cell analysis. This technology has seen strong adoption and sales globally, and we continue to improve and expand this product offering.
In 2019, we completed a Series B round of funding, raising US $15M from a consortium of venture capital organizations including KB Investments, IMM Investments, Quad Investments, HB Investments, DayLI Investments, and SV Investments in Korea.